About BEC Chemicals
BEC Chemicals is a Healthcare company based in Mumbai (India) founded in 1979 by M T Shah. It manufactures APIs, intermediates, and chemicals for global markets via contract services. It operates on a B2B and Export Manufacturing model in Healthcare and Chemicals & Materials sectors. The company has 282 employees. Its Indian entity B E C Chemicals Private Limited reported revenue of ₹131 Cr. BEC Chemicals offers products and services including Active Pharmaceutical Ingredients, Intermediates, Specialty Chemicals, Contract Manufacturing, and Contract Research & Development. Its focus areas include Pharmaceutical Manufacturing, API Production, Chemical Intermediates and Chemicals. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
BEC Chemicals Pvt. Ltd. specializes in producing active pharmaceutical ingredients, intermediates, and specialty chemicals through contract manufacturing and research. Operating primarily from Mumbai, India, with facilities in Roha and Saykha, they focus on high-quality, environmentally compliant processes. They serve global clients by exporting products and adhering to international standards like GMP and ICH Q7, emphasizing innovation and sustainability.
- Headquarters Mumbai, India
- Employees 282
- Founders M T Shah
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website becchemicals.com
- Social LinkedIn
- Legal Name B E C Chemicals Private Limited
- Date of Incorporation 10 Dec, 1958
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹131 Cr
FY 2025 · -7% YoY
- Net Profit₹7.09 Cr
FY 2025 · 5% margin
- EBITDA₹20.23 Cr
FY 2025 · 15% margin
- Employee Count282
Associated legal entities of BEC Chemicals
BEC Chemicals is associated with 3 registered companies on The Company Check; the primary company is B E C Chemicals Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| B E C Chemicals Private Limited CIN U28932MH1958PTC011230 | Active | 10 Dec 1958 | Mumbai, Maharashtra | ₹131 Cr | 282 | 6 | View details |
| Mechamorphosis Llp CIN AAX-0062 | Active | 13 May 2021 | Mumbai, Maharashtra | – | – | 2 | View details |
| Bec Industrial Investment Company Private Limited CIN U24100MH1978PTC020565 | Active | 09 Aug 1978 | Mumbai, Maharashtra | ₹147 Cr | – | 4 | View details |
Products & Services of BEC Chemicals
BEC Chemicals offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, Specialty Chemicals, Contract Manufacturing, and Contract Research & Development.
Produces high-quality APIs for pharmaceutical use globally.
Supplies intermediates for drug synthesis and manufacturing.
Offers specialty chemicals for various industrial applications.
Provides custom manufacturing services for pharmaceutical needs.
Delivers research and development for chemical innovations.
Performs particle size reduction for pharmaceutical materials.
Board of directors of B E C Chemicals Private Limited (BEC Chemicals)
B E C Chemicals Private Limited is the primary company behind BEC Chemicals. The boards of the 3 registered companies of BEC Chemicals currently have 9 directors; the longest-serving is Chandulal Talakchand Shah, appointed in 1978. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandulal Talakchand Shah DIN 00116643 | Director | 09 Aug 1978 | 48 yrs 2 mo | Bec Industrial Investment Company Private Limited |
| Jayesh Chandulal Shah DIN 00116737 | Director | 25 Dec 2001 | 24 yrs 9 mo | B E C Chemicals Private Limited |
| Varsha Dinesh Shah DIN 00116494 | Director | 17 Mar 2005 | 21 yrs 7 mo | Bec Industrial Investment Company Private Limited |
| Yuvraj Vijay Papriwal DIN 00232125 | Designated Partner | 13 May 2021 | 5 yrs 5 mo | Mechamorphosis Llp |
| Pushkar Dinesh Shah DIN 01350273 | Designated Partner | 13 May 2021 | 5 yrs 5 mo | Mechamorphosis Llp, B E C Chemicals Private Limited, Bec Industrial Investment Company Private Limited |
| Megha Dinesh Shah DIN 02809985 | Director | 16 Oct 2021 | 5 yrs | B E C Chemicals Private Limited, Bec Industrial Investment Company Private Limited |
| Milind Uttamrao Rajurkar DIN 09741219 | Director | 19 Sep 2022 | 4 yrs | B E C Chemicals Private Limited |
| Sameer Vasant Pawar DIN 10776046 | Director | 16 Sep 2024 | 2 yrs 1 mo | B E C Chemicals Private Limited |
| Manoj Suresh Angre DIN 10773563 | Director | 16 Sep 2024 | 2 yrs 1 mo | B E C Chemicals Private Limited |
People of BEC Chemicals
29 people are tracked at BEC Chemicals (3 in leadership, 26 in team); the tracked headcount is 282.
| Name | Role | Group |
|---|---|---|
M T Shah | Founder | Leadership |
Manish Kothari | CEO | Leadership |
Venkateswarlu Mulagada | General Manager - Finance And Accounts | Leadership |
Dr Rahul Betkar | Research Associate | Team |
Pooja Pumbhadiya (Prajapati) | Junior Research Associate | Team |
Mukesh Panchal | Outsourcing Manager | Team |
Dinesh Khambat | Juniour Research Associate | Team |
Kerry McKenna | Sales | Team |
Manish Patil | Assistant Manager | Team |
Shital Karde | Account Executive | Team |
Lalit Khairnar | Sr. Research Associate | Team |
Kunal Shinde | Quality Control Officer | Team |
Palande Prathmesh | Executive Quality Assurance | Team |
Vikas Dixit | DGM | Team |
Mayuri Nikam | Junior Research Associate | Team |
Ajay Dapke | Manager Excise And Logestics | Team |
Vishal Karande | Finance Manager | Team |
Ruchi Shah | Senior HR Manager | Team |
Ashish Shahare | Marketing Manager | Team |
Chetan Nale | Executive-microbiologist | Team |
9 more people are available in the full profile.
Complete people profiles for BEC Chemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of BEC Chemicals
Figures of B E C Chemicals Private Limited, the primary company behind BEC Chemicals, for FY 2025. Revenue was ₹131 Cr (-7% year on year). Net profit was ₹7.09 Cr (5% margin). EBITDA was ₹20.23 Cr (15% margin). Revenue has grown at a compounded annual rate of +14% over three years and +9% over five years.
- ₹131 CrRevenue · FY 2025 · -7% YoY
- ₹7.09 CrNet profit · 5% margin
- ₹20.23 CrEBITDA · 15% margin
- ₹90 LakhPaid-up capital
- 282Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of B E C Chemicals Private Limited are on its company page.
Detailed financial statements for BEC Chemicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to BEC Chemicals
BEC Chemicals has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of BEC Chemicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BEC Chemicals
Websites that share an audience with BEC Chemicals (becchemicals.com).
Websites whose visitors overlap most with BEC Chemicals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neelikon.com | 100% | 3.3K | #5,389,975 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as BEC Chemicals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bec Chemicals
Complete news archive for BEC Chemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BEC Chemicals
BEC Chemicals was founded in 1979.
BEC Chemicals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
BEC Chemicals has 282 employees.
The primary company behind BEC Chemicals, B E C Chemicals Private Limited, reported revenue of ₹131 Cr for FY 2025, down 7% year on year.
BEC Chemicals Pvt. Ltd. specializes in producing active pharmaceutical ingredients, intermediates, and specialty chemicals through contract manufacturing and research. Operating primarily from Mumbai, India, with facilities in Roha and Saykha, they focus on high-quality, environmentally compliant processes. They serve global clients by exporting products and adhering to international standards like GMP and ICH Q7, emphasizing innovation and sustainability.
BEC Chemicals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
BEC Chemicals offers Active Pharmaceutical Ingredients, Intermediates, Specialty Chemicals, Contract Manufacturing, and 2 more products and services.
BEC Chemicals is associated with 3 legal entities: B E C Chemicals Private Limited, Mechamorphosis Llp, Bec Industrial Investment Company Private Limited.
The legal entities of BEC Chemicals currently have 9 directors, including Yuvraj Vijay Papriwal, Pushkar Dinesh Shah, Megha Dinesh Shah and others.